{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Amgen", "item": "https://www.patentleaderboard.com/2021/company/amgen"}, {"@type": "ListItem", "position": 4, "name": "Longbin Liu", "item": "https://www.patentleaderboard.com/2021/inventor/fl:lo_ln:liu-5"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
LL

Longbin Liu — 3 Patents in 2021

AMAmgen: 2 patents #57 of 505Top 15%
NHNovagen Holding: 1 patents #1 of 5Top 20%
Thousand Oaks, CA: #29 of 209 inventorsTop 15%
California: #8,414 of 66,859 inventorsTop 15%
Overall (2021): #73,075 of 548,734Top 15%
3 Patents 2021

Issued Patents 2021

Showing 1–3 of 3 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
11090304 KRAS G12C inhibitors and methods of using the same John Gordon Allen, Jennifer R. Allen, Ana Elena Minatti, Qiufen Xue, Ryan Wurz +22 more 2021-08-17 $335,995,000
11028398 Fusion proteins having mutated immunoglobulin hinge region Haitao Wang, Yong Du, Rui Zhang, Jing Xu 2021-06-08
11021493 1,4-thiazine dioxide and 1,2,4-thiadiazine dioxide derivatives as beta-secretase inhibitors and methods of use Jennifer R. Allen, Matthew P. Bourbeau, James Brown, Ning Chen, Michael J. Frohn +6 more 2021-06-01 $258,451,000